A safety and efficacy trial of bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor.
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology